Human factor XIII as a normalization control for immunoassays
US-9658220-B2 · May 23, 2017 · US
US9797902B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9797902-B2 |
| Application number | US-201715492905-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 20, 2017 |
| Priority date | Jun 22, 2012 |
| Publication date | Oct 24, 2017 |
| Grant date | Oct 24, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides compositions and methods that are useful for normalizing the amount of signal detected in an assay, such as an immunoassay. The compositions and methods are useful for improving the accuracy of immunoassays, such as immunoassays that detect whether a subject is infected with a retrovirus such as HIV.
Opening claim text (preview).
What is claimed is: 1. A kit for determining whether a subject is infected with HIV or a stage of infection of a subject so infected, said kit comprising a normalization factor immobilized on a solid support, and a plurality of binding members, each binding member immobilized on a solid support, said plurality comprising: (i) anti-p24 antibody, (ii) HIV-1 envelope protein gp-160, (ii) HIV-2 SPOH (RVTAIEKYLQDQARLNSWGCAFRQVC (SEQ ID NO:5)), and (iv) HIV-O AFR (LNQQRLLNSWGCKGRLVCYTSV (SEQ ID NO:2)); said solid supports further bearing differentiation parameters selected such that all said supports bearing any one binding member of said plurality are differentiable from all said supports bearing other binding members of said plurality. 2. The kit of claim 1 , wherein the normalization factor does not bind an analyte from the biological sample. 3. The kit of claim 1 , wherein the normalization factor is hFXIII. 4. The kit of claim 1 , further comprising an antibody to human Factor XIII immobilized on a solid support. 5. The kit of claim 1 , further comprising tetramethylcadaverine rhodamine (TMRC) immobilized on a solid support. 6. The kit of claim 1 , wherein the solid supports are beads or magnetic beads.
Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII · CPC title
Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII · CPC title
Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding · CPC title
Enzymes or microbial cells immobilised on or in an inorganic carrier · CPC title
HIV or HTLV · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.